Leye He
Central South University
27 Papers
118 Citations
Leye He is an academic researcher from Central South University. The author has contributed to research in topics: Erectile dysfunction & Prostate cancer. The author has an hindex of 6, co-authored 24 publications.
Chat about Author
Papers
The prognostic role of preoperative serum albumin/globulin ratio in patients with bladder urothelial carcinoma undergoing radical cystectomy
Jianye Liu,Yingbo Dai,Fangjian Zhou,Zhi Long,Yonghong Li,Bin Liu,Dan Xie,Jin Tang,Jing Tan,Kun Yao,Yi-Chuan Zhang,Yuxin Tang,Leye He +12 more
TL;DR: High AGR is a strong independent predictor of long-term RFS and CSS in patients with BUC undergoing RC and among patients with normal albumin levels, patients with higher globulin, but lower AGR have worse survival.
80
Delivery of RIPK4 small interfering RNA for bladder cancer therapy using natural halloysite nanotubes
Jianye Liu,Yi Zhang,Zeng Qinghai,Hongliang Zeng,Xiao Ming Liu,Pei Wu,Hongyi Xie,Leye He,Zhi Long,Xiaoyong Lu,Mengqing Xiao,Yuxing Zhu,Hao Bo,Cao Ke +13 more
TL;DR: It is revealed that natural halloysite nanotube–assisted delivery of an active small interfering RNA (siRNA) targeting receptor-interacting protein kinase 4 (RIPK4) efficiently silenced its expression to treat bladder cancer.
59
Animal models of benign prostatic hyperplasia.
Junjie Zhang,Mengda Zhang,Jin Tang,Guangming Yin,Zhi Long,Leye He,Chuanchi zhou,Lufeng luo,Lin Qi,Long Wang +9 more
TL;DR: The present status quo for animal models of B PH is outlined, comparing the pros and cons with respect to their ability to mimic the etiological, histological, and clinical hallmarks of BPH and their applicability for future research is discussed.
33
ZHX3 promotes the progression of urothelial carcinoma of the bladder via repressing of RGS2 and is a novel substrate of TRIM21.
Minhua Deng,Wensu Wei,Jin-Ling Duan,Rixin Chen,Ning Wang,Leye He,Yulu Peng,Xiao-Dan Ma,Zeshen Wu,Jianye Liu,Zhiyong Li,Zhiling Zhang,Lijuan Jiang,Fangjian Zhou,Dan Xie +14 more
TL;DR: Zhang et al. as discussed by the authors found that ZHX3 could promote the migration and invasion capacities of urothelial carcinoma of the bladder (UCB) cells both in vitro and in vivo.
29
MicroRNA-124 inhibits cell proliferation, invasion and migration by targeting CAV1 in bladder cancer.
TL;DR: It is demonstrated that miR-124 has a suppressive role in the proliferation, migration and invasion of BC cells by targeting CAV1, which suggests that mi R-124 is a potential therapeutic candidate for BC.